All data are based on the daily closing price as of March 19, 2025
k

Korea United Pharm

033270.KO
14.23 USD
0.13
+0.92%

Overview

Last close
14.23 usd
Market cap
209.40M usd
52 week high
21.00 usd
52 week low
12.07 usd
Target price
25.63 usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
1.8362
Price/Book Value
0.7584
Enterprise Value
142.81M usd
EV/Revenue
0.7196
EV/EBITDA
4.7459

Key financials

Revenue TTM
111.82M usd
Gross Profit TTM
56.10M usd
EBITDA TTM
21.11M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
348.76M usd
Net debt
N/A usd

About

Korea United Pharm Inc. engages in the manufacture and sale of pharmaceutical products in South Korea. It offers products in the areas of respiratory system, musculo-skeletal system, gastro-intestinal tract system, cardiovascular system, anti-cancer, anti-infectives, allergy, immune system, central nervous system, and other diseases, as well OTC drugs. The company also exports its products to approximately 40 countries. Korea United Pharm Inc. was founded in 1987 and is headquartered in Seoul, South Korea.
  • Symbol
    033270.KO
  • Exchange
    KO
  • Isin
    KR7033270000
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
  • Headquarter
    Seoul
  • Web site
    https://www.kup.co.kr
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top